Skin

Skin is sometimes treated as though it were a transparent wrapper around the anatomy underneath it. It is not. It is an active organ with its own barrier, immune system, pigment biology, vascular responses, appendages and connective-tissue structure. It repairs wounds, responds to ultraviolet radiation, produces pigment after inflammation and changes continuously with hormones, age, environment and the products we place on it.

This is why the word “skin rejuvenation” is too broad to be a diagnosis. A patient can want brighter skin because of superficial roughness, because pigment has become uneven, because inflammatory redness changes the colour, because acne scars disrupt light reflection or because deeper facial volume loss is casting shadows that have nothing to do with skin quality. The mirror shows one tired surface; the biology underneath may contain several unrelated problems.

I therefore think skin treatment begins with definition. What exactly looks different? Is the problem colour, texture, inflammation, hydration, scarring, elasticity or a structure underneath the skin being interpreted as a skin problem? Once that distinction is made, treatment can become surprisingly simple. Without it, a patient can undergo an impressive sequence of lasers, injections and peels while the dominant mechanism remains untouched.

The epidermis and dermis create different kinds of skin problems

The epidermis forms the outermost living layers of the skin, while the stratum corneum at its surface provides much of the barrier separating the body from the environment. Epidermal turnover influences surface smoothness, and melanocytes within the basal region contribute to pigmentation. Many superficial roughness and pigment problems therefore begin relatively close to the surface, although pigment can also sit deeper and behave very differently depending on the condition.

The dermis contains collagen, elastin, blood vessels and extracellular matrix that give the skin much of its mechanical strength and resilience. Fine wrinkling, atrophic scars and some forms of laxity therefore involve structural change beneath the epidermal surface. A peel that improves superficial keratinisation and a microneedling or energy treatment designed to remodel dermal tissue are not stronger and weaker versions of one treatment. They are acting at different biological layers.

This distinction helps prevent escalation for its own sake. If the problem is mostly superficial, creating a larger dermal wound can expose the patient to unnecessary inflammation and recovery. If a scar extends into the dermis, repeatedly polishing the epidermis cannot reconstruct the architecture underneath. Depth is useful only when it matches the depth of the problem.

Skin treatment should not start by asking how aggressive a procedure can be. It should start by asking how deep the problem actually is.

A stable barrier is the baseline from which almost every elective skin treatment becomes more predictable

The skin barrier limits water loss and regulates exposure to the external environment. When it becomes disrupted, patients can develop burning, tightness, flaking and increased sensitivity to products they previously tolerated. Ironically, this state is often described by patients as rough, dull or congested skin, which can lead them to add more acids, scrubs, retinoids and professional exfoliation.

That can create a cycle in which the treatment for perceived poor skin quality becomes the cause of poor skin quality. An inflamed barrier reflects light badly, retains water poorly and makes pigment more reactive. Performing another peel or abrasive procedure may produce a few smooth days before the inflammatory state becomes more persistent.

This is why there are consultations in which I would begin with less treatment rather than more. Simplifying the routine, restoring hydration, reducing unnecessary irritants and allowing inflammation to settle can reveal which concerns actually remain once the barrier is behaving normally again. Sometimes the most sophisticated intervention is recognising that the skin first needs to be left alone.

Pigmentation is not one problem simply because several conditions look brown

Sun-related lentigines, freckles, melasma and post-inflammatory hyperpigmentation can all create brown or grey areas on the skin, but their biology and treatment behaviour differ. A discrete sunspot may be a relatively local accumulation of pigment. Melasma is a chronic, reactive pigment disorder influenced by ultraviolet exposure, visible light, hormones and inflammation. PIH is created by inflammation itself and can therefore be worsened by the very procedure intended to remove it.

This distinction becomes even more important in darker and pigment-reactive skin. The objective is never to remove as much melanin as possible. Normal epidermal melanin is protective and contributes to the patient’s natural skin colour. A laser or peel cannot morally or biologically distinguish “wanted” from “unwanted” pigment unless the treatment parameters and lesion biology create that selectivity.

I also do not cosmetically destroy a changing or diagnostically uncertain pigmented lesion simply because a device can make the colour disappear. A lesion that requires medical or histopathological assessment should be diagnosed first. Cosmetic success is not removing the evidence before we know what the evidence represented.

Redness can be vascular, inflammatory or simply a temporary physiological response

Persistent facial redness may arise from rosacea, visible superficial vessels, chronic irritation or another inflammatory skin condition. Temporary redness after exercise, heat or a procedure is another phenomenon. Treating all of these with one vascular device because the colour is red ignores the biological reason the vessels are visible.

When discrete vascular targets are dominant, light and laser technologies can be useful. When inflammatory rosacea is active, the vascular appearance belongs inside a broader disease-management plan. When barrier damage is creating erythema, another energy treatment can worsen the inflammation rather than treating the reason the face is red.

Again, colour is an outcome rather than a diagnosis. The same shade can arise from blood flow, inflammation, pigment or a mixture. A useful skin consultation has to move from what the eye sees to what the tissue is doing.

Texture problems should be separated into surface irregularity and structural irregularity

Dryness, superficial keratin accumulation and mild photodamage can produce a rough surface. Treatments that renew the epidermis—including selected skincare and controlled peeling—may be sufficient. Skin rejuvenation should therefore not automatically mean a high-energy intervention; the correct treatment can be modest when the defect is modest.

Acne scars are different. Atrophic scars can be narrow and deep, sharply edged, broad and depressed or mechanically tethered beneath the surface. Each architecture interacts with light differently and each may require a different strategy. Microneedling can provide useful dermal remodelling in selected scars, but a tethered rolling scar may require release of the tether, while a very deep narrow scar may respond better to another focal mechanism.

The same logic applies to pores. Follicular openings are normal anatomy. Sebum production, surrounding collagen support and surface texture influence how visible they appear. No treatment permanently closes them because they do not function like doors. Improving oil control or dermal support can make them less conspicuous, but the endpoint should remain normal skin rather than a poreless digital surface.

Acne deserves disease control before cosmetic correction of its consequences

Active acne can create papules, pustules, nodules, pigmentation and permanent scars. Those are not equal treatment priorities. If inflammatory disease continues producing new lesions, spending months treating old pigmentation or scars while new scars are forming reverses the sensible sequence.

This is why I separate active acne from post-acne skin. The first requires control of the process producing lesions. The second may require treatment of residual pigment, erythema or scar architecture after the disease is stable enough that new injury is no longer dominating the picture. A peel, light treatment or microneedling session can have a role in selected acne-related concerns, but none should become an excuse to under-treat clinically significant active disease.

That distinction is particularly important because aesthetic procedures can feel more attractive than medication. They are tangible and immediate. But a treatment being procedural does not make it more advanced. The more sophisticated choice is the one that prevents another permanent scar from being created.

Skin ageing is a combination of intrinsic biology and accumulated exposure

With time, epidermal turnover changes, dermal collagen and elastic architecture alter, hydration can decrease and the skin’s ability to recover from environmental stress becomes different. Ultraviolet exposure adds another layer through photoageing, producing uneven pigment, texture change, vascular features and collagen degradation. Smoking and other environmental factors can further influence these processes.

This does not create one universal “anti-aging” treatment because ageing is not one lesion. A patient with predominantly pigment change requires a different strategy from a patient with fine dermal wrinkling. Early laxity and thin crepey skin are another problem. Significant tissue descent lies partly outside the skin altogether and cannot be corrected by asking the dermis to produce more collagen indefinitely.

I am therefore careful with the phrase collagen stimulation. Many treatments can influence collagen biology—microneedling, RF, lasers and biostimulatory injectables among them. But a collagen response does not tell us the magnitude or direction of the visible result. Improving dermal support can make skin quality better; it cannot mechanically return a descended facial fat compartment to its former position.

Scars need to be read as tissue architecture rather than as a single category of damaged skin

A scar can be raised, depressed, tethered, widened, pigmented, red or a combination of several features. Hypertrophic and keloid scars involve excessive scar production and behave differently from atrophic acne scars. A surgical scar may be wide because of tension, while another may be narrow but conspicuous because of colour contrast. Stretch marks are another form of dermal structural change and should not be treated as ordinary surface pigmentation.

This matters because there is no universally best scar treatment. A vascular laser may improve redness without changing depression. Mechanical release can correct tethering without correcting pigment. Resurfacing can improve surface transition without eliminating a wide scar. Steroid treatment can be useful for selected raised scars but would obviously be inappropriate for an atrophic depression.

I often think of scar treatment as a process of identifying the feature that is still abnormal rather than trying to erase the concept of a scar. A mature scar is replacement tissue. Complete return to uninjured skin is rarely a realistic endpoint. The useful goal is to reduce the characteristic that makes the scar disproportionately visible or symptomatic.

Skin thickness and body region change how the same treatment behaves

Facial skin, eyelid skin, neck skin, chest skin and body skin do not heal identically. Thickness, sebaceous density, vascularity and appendage density vary. The face generally has a rich supply of pilosebaceous units that can contribute to re-epithelialisation after resurfacing; the neck and some body regions can have a narrower safety margin for aggressive treatment.

This is why a laser setting that is appropriate for one facial region should not simply be copied onto the neck or body. The same is true of chemical peeling, microneedling depth and energy-based treatment. “Full face and neck” sounds like one treatment area on a price list, but biologically it contains tissues with different recovery behaviour.

Previous treatment can alter that behaviour further. Repeated aggressive resurfacing, chronic inflammation, scarring or previous surgery can change tissue response. The fact that the patient tolerated one procedure several years ago does not automatically establish that the current skin has the same margin today.

How I assess skin is a diagnosis of mechanisms before it becomes a treatment sequence

I begin by asking what the patient actually sees: colour, texture, dryness, pores, scars, redness, laxity or another change. Then I look for the biological driver. The barrier is assessed because irritated skin can imitate several aesthetic problems. Pigment pattern and inflammatory activity are evaluated. Scar architecture is examined with directional light. Skin thickness and elasticity are considered, along with sun exposure, skincare, medications and previous procedures.

I also ask whether the perceived problem really belongs to the skin. An under-eye shadow can come from skeletal and soft-tissue contour. A deep nasolabial fold is not primarily an epidermal defect. A lower face that looks heavy may reflect fat distribution or tissue descent. Treating these as “skin ageing” can expose normal skin to increasingly aggressive procedures while the deeper structure creating the appearance remains unchanged.

Only after that do treatment categories become useful. A stable superficial problem may respond to skincare or peeling. Pigment may require topical control, light, laser or another targeted strategy depending on diagnosis. Structural texture and scars can justify controlled remodelling. Early laxity may respond partially to energy or biostimulation. A suspicious lesion belongs to medical diagnosis, and advanced tissue descent may belong to surgery rather than another skin treatment.

I do not treat the word rejuvenation. I treat the mechanism that made the skin look different in the first place.

Combination treatment is useful when the skin genuinely contains more than one mechanism

Real skin often contains several problems simultaneously. A patient may have sun-related pigment, superficial roughness and early dermal laxity. Another may have active acne, PIH and old atrophic scars. It can therefore be rational to use different treatments over time because each solves a separate layer.

What I avoid is combination for its own sake. Performing a peel, microneedling, RF, injectable booster and LED simply because each can be described as rejuvenating creates a larger treatment burden without proving that every component is necessary. The second or third treatment should add a mechanism that the first treatment does not already address.

Sequencing also matters. Pigment-reactive skin may need inflammation controlled before a more aggressive procedure. Active acne may need stabilisation before scar treatment. A powerful resurfacing procedure should be allowed to heal and remodel before another inflammatory treatment is added simply because the next appointment was already sold.

The purpose of combining treatments is to solve complexity without creating unnecessary complexity.

Good skin does not require permanent treatment

Aesthetic medicine can create the impression that healthy skin is always one appointment away from deterioration. I do not think that is a useful model. Photoprotection, appropriate skincare and basic health behaviour can carry much of the long-term work. Procedures have a role when there is a defined concern whose expected improvement is worth the intervention.

Maintenance can be reasonable when a chronic biological tendency continues—for example recurrent photodamage or a condition requiring ongoing control. But a patient whose skin is stable and satisfactory does not need a new injury simply because six months have passed. More procedures are not a marker that the skin is being cared for more seriously.

There is a ceiling to useful correction. Normal pores remain visible, expression creates lines, pigment varies subtly and skin moves because it is living tissue. A treatment plan that begins by respecting those facts is less likely to turn normal texture into a defect that has to be managed indefinitely.

When does a skin consultation make sense?

Consultation becomes useful when a concern persists despite a sensible routine, when several problems overlap and you are unsure which should be treated first, or when previous procedures have produced disappointing or confusing results. You do not need to arrive asking for a particular laser, peel or injectable. In many cases, deciding which category the problem belongs to is the most valuable part of the assessment.

I would also seek medical evaluation rather than cosmetic treatment for lesions that are new, changing, bleeding, ulcerated or otherwise suspicious. The aesthetic clinic should never make diagnosis less important simply because technology exists that can remove a visible mark.

The best treatment plan can therefore range from a carefully selected procedure to a simpler skincare programme, referral for medical dermatological management or no treatment at all. Skin is not improved by the number of interventions it survives. It is improved when the correct biological problem receives enough treatment—and no more than enough.

Frequently asked questions

How do I know which skin treatment I need?

You do not need to know before consultation. Pigmentation, redness, texture, scars, laxity and barrier problems arise from different mechanisms and often require different treatments. The useful first step is identifying what layer and process are creating the visible concern.

Is laser the strongest treatment for skin rejuvenation?

There is no universally strongest or best modality. Lasers can be highly useful when their wavelength and tissue effect match the target, but some concerns are better addressed with skincare, peeling, microneedling, RF, injectables or another strategy. Greater injury is not automatically greater relevance.

Can one treatment fix pigment, pores, scars and laxity at the same time?

One treatment may improve more than one feature, but these concerns do not share one mechanism. Combination or staged treatment can be rational when several genuine problems coexist, although every added procedure should have a separate reason to be included.

Why does my skin sometimes look worse when I use more active skincare?

Excessive acids, retinoids, scrubs or other irritating products can disrupt the barrier and create redness, dryness, roughness and pigment reactivity. Those changes can resemble the skin problems the products were intended to improve. In that situation, restoring stability may be more useful than adding another active.

Can skin treatments lift a sagging face?

They can improve selected dermal quality and early laxity, but significant facial descent involves deeper fat, ligamentous and structural relationships. Improving skin support is not the same mechanical event as repositioning descended tissue, and the two should not be promised as equivalent.